ResearcherNo recent work listed

Peter Wang

Provisional: name only (low confidence, 0.40), identity_conf@1As of 7 November 2026

Known by name only; no external author ID or institution yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Last author DOI 10.3389/fonc.2022.1004212 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fei Chen · 1 shared paper, 2022 · strength 0.16
- Paper LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. DOI 10.3389/fonc.2022.1004212 ↗
Xiaorong Liu · 1 shared paper, 2022 · strength 0.16
- Paper LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. DOI 10.3389/fonc.2022.1004212 ↗
Zhengwei Song · 1 shared paper, 2022 · strength 0.16
- Paper LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. DOI 10.3389/fonc.2022.1004212 ↗
Xiaoguang Wang · 1 shared paper, 2022 · strength 0.16
- Paper LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. DOI 10.3389/fonc.2022.1004212 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.